Dr. Tao Jiang received his Ph.D. in Cell Biology from Southern Medical University, completed doctoral exchange training at the University of California, San Diego (UCSD), and conducted postdoctoral research at the Southern University of Science and Technology. His research focuses on innovative drug development for cancer, including mRNA-based immunotherapeutic strategies, antibody–drug conjugates (ADCs) and other antibody therapeutics, as well as combination immunotherapies. He utilizes humanized mouse models and other systems for preclinical drug evaluation, aiming to develop novel approaches to overcome the immunosuppressive tumor microenvironment. Dr. Jiang has participated in several national and provincial key R&D projects, has published research as first author or corresponding author in international journals such as Advanced Science, and holds one invention patent.